代表的な研究業績 平松 正行
(Last updated, March 16, 1999, by M. Hiramatsu）
28. Masayuki
Hiramatsu, Hiroyasu Murasawa, Hiromasa
Mori, and Tsutomu Kameyama: Kappa-opioid receptor agonists prevent
impairment of learning and memory accompanied by modulation in
cholinergic neuronal system, The 13th Korea-Japan Joint Seminar on
Pharmacology, Seoul，1996, 11．
27. Masayuki Hiramatsu, Hiroyasu Murasawa, Hiromasa Mori, and Tsutomu Kameyama:
Dynorphin A (1-13) improves carbachol-induced impairment of learning
accompanied by blockage of reduction in acetylcholine release in rat,
5th International Conference on Alzheimer's Disease and Related
Disorders, Osaka，1996, 7．
26. Masayuki Hiramatsu, Hiroyasu Murasawa, Hiromasa Mori, and Tsutomu Kameyama:
Effect of dynorphin A (1-13) on decrease in acetylcholine release
induced by carbachol in rats，20th C.I.N.P. Congress,
Melbourne，1996, 6．
25. Masayuki Hiramatsu, Mayumi Sasaki, Tsutomu Kameyama，Effects of dynorphin A
(1-13) on carbon monoxide (CO)-induced delayed amnesia in mice using
a step-down type passive avoidance task，IUPHAR 12th International
Congress of Pharmacoclogy, Montreal, Canada，1994, 7．
24. Tsutomu Kameyama, Masayuki
Hiramatsu, Mayumi Sasaki，Effects of
dynorphin A (1-13) on the carbon monoxide (CO)-induced impairment of
spontaneous alternation performance in mice，IUPHAR 12th
International Congress of Pharmacoclogy, Montreal, Canada，1994,
7．
23. Masayuki Hiramatsu, Hisae Satoh, Masaaki Murai, Tsutomu Kameyama, Toshitaka
Nabeshima，Studies of (-)-nicotine on carbon monoxide-induced
learning impairment in mice，2nd International Nicotine Synposium,
St. Adele, Canada，1994, 7．
22. Masayuki Hiramatsu, Hirotaka Suzuki, Toshitaka Nabeshima, Tsutomu
Kameyama，Effects of quinolinic acid injected into the rat striatum
and frontal cortex on learning and memory，XIXth Congress of
Collegium Internationale Neuro-Psychopharmacologicum, Washington
D.C., U.S.A.，1994, 6．
21. Tangui Maurice, Masayuki
Hiramatsu, Jiro Itoh, Tsutomu Kameyama,
Takaaki Hasegawa, Toshitaka Nabeshima，Protection against carbon
monoxide (CO)-induced amnesia by cholecystokinin (CCK)-related
peptides differently involve CCK-A and CCK-B receptors，XIV
International Soceity for Neurochemistry Biennial Meeting,
Montpellier, France，1993，8．
20. Tangui Maurice, Masayuki
Hiramatsu, Jiro Itoh, Tsutomu Kameyama,
Takaaki Hasegawa, Toshitaka Nabeshima，Cholecyctokinin-related
peptides, ceruletide and CCK-8, protect against carbon monoxide
(CO)-induced amnesia in mice，XVI International Symposium on Cerebral
Blood Flow and Metabolism, Sendai Japan，1993, 5．
19. Toshitaka Nabeshima, Masayuki
Hiramatsu, Tsutomu Kameyama, Tadashi
Shiotani，Involvement of the cholinergic system in antiamnesic
effects of nefirasetam (DM-9384)，8th International Cholinergic
Symposium, Montreal, Canada，1992, 7．
18. Toshitaka Nabeshima, Kazuyuki Fuji, Masayuki Hiramatsu, Tsutomu
Kameyama，Effects of propentofylline (PPF) on basal forebrain
lesion-induced amnesia in rats，XVIIIth Congress of Collegium
Internationale Neuro-Psychopharmacologicum, Nice, France，1992,
6．
17. Toshitaka Nabeshima, Masayuki
Hiramatsu, Kiriko Niwa, Kenji Ichihara,
Keiko Tohyama, Kenshi Murase, Takako Suzuki, Tsutomu
Kameyama，Antiamnesic effects of naftidrofuryl oxalate (LS-121) in
relation to serotonin (5-HT)2 receptors，Satellite
Symposium of International Congress of Biochemistry: Advances in
Tryptophan Research, Nagoya，1992, 5．
16. Toshitaka Nabeshima, Hirohisa Ishimaru, Akira Katoh,
Masayuki Hiramatsu, Hirotaka Suzuki, Taneo Fukuta, Tsutomu Kameyama，NMDA
receptor antagonists protect carbon monoxide-induced delayed neuronal
death，Third U.S.-French Sponsored International Seminar: Multiple
Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and
Protection?, La Grande Motte, France，1991, 9．
15. Toshitaka Nabeshima, Masayuki
Hiramatsu, Akira Katoh, Sei-ichi Ishihara,
Hirohisa Ishimaru, Hiroko Ichihashi, Tomomi Koide, Tadashi Shiotani,
Tsutomu Kameyama，Involvement of cholinergic system in effects of
DM-9384 on carbon monoxide (CO)-induced acute and delayed
amnesia，Satellite Symposium of XVth International Symposium on
Cerebral Blood Flow and Metabolism, Key West, U.S.A.，1991, 6．
14. Arthur K. Cho, Masayuki
Hiramatsu, Toshitaka Nabeshima, Tsutomu
Kameyama，Pharmacokinetic and pharmacodynamic properties of
phencyclidine analogs，Satellite Symposium of XVIIth Congress of
Collegium Internationale，Neuro-Psychopharmacologicum, Nagoya，1990,
9．
13. Masayuki Hiramatsu, Emma W. DiStefano, Ann S. Chang, Donald J. Jenden,
Tsutomu Kameyama, Arthur K. Cho，Stereochemical differences in the
metabolism of 3,4-methylenedioxymethamphetamine (MDMA)，XVIIth
Congress of Collegium Internationale Neuro-Psychopharmacologicum,
Kyoto，1990, 9．
12. Masayuki Hiramatsu, Arthur K. Cho，Comparison of the behavioral and
biochemical effects of the NMDA receptor antagonists, MK-801 and
phencyclidine，XVIth Congress of Collegium Internationale
Neuro-Psychopharmacologicum, Munich, West Germany，1988, 8．
11. Masayuki Hiramatsu, Toshitaka Nabeshima, Kazumasa Yamaguchi, Kimie Ishizaki,
Tsutomu Kameyama, Hiroshi Furukawa，A study of the neurobehavioral
development in rats treated neonatally with phencyclidine，IUPHAR
10th International Congress of Pharmacoclogy, Sydney,
Australia，1987, 8．
10. Motoi Yogo, Kazue Okayama, Toshitaka Nabeshima, Masayuki Hiramatsu, Tsutomu
Kameyama, Hiroshi Furukawa，Synthesis and properties of phencyclidine
analogues having polyether function，XIth International Congress of
Heterocyclic Chemistry, Heidelberg, Federal Republic of
Germany，1987, 8．
9. Motoi Yogo, Kazue Okayama, Toshitaka Nabeshima, Masayuki Hiramatsu, Tsutomu
Kameyama, Hiroshi Furukawa，Synthesis and properties of phencyclidine
analogues having multideutate monocyclic ligand，The 12th
International Symposium on Macrocyclic Chemistry, Hiroshima，1987,
7．
8. Masayuki Hiramatsu, Toshitaka Nabeshima, Hiroshi Furukawa, Tsutomu
Kameyama，Ethylketocyclazocine (EKC) antagonizes phencyclidine
(PCP)-induced stereotyped behaviors by reducing monoamine
release，Second U.S.-French Sponsored International Seminar: Sigma
Opioid/Phencyclidine-like Compounds as Molecular Probes in Biology,
Ann Arbor, U.S.A.，1987, 7．
7. Toshitaka Nabeshima, Kazumasa Yamaguchi, Masayuki Hiramatsu, Kazuhiro
Ishikawa, Hiroshi Furukawa, Tsutomu Kameyama，Effects of prenatal
administration of phencyclidine on the behavior of rat
offspring，Satellite Symposium of IVth International Congress of
Toxicology, Tokyo，1986, 7．
6. Toshitaka Nabeshima, Kazumasa Yamaguchi, Masayuki Hiramatsu, Akira
Sugimoto, Shigeru Yoshida, Hiroaki Fukaya, Hiroshi Furukawa, Tsutomu
Kameyama，Development of tolerance and supersensitivity in rats
treated with phencyclidine (PCP) chronically，ACNP Annual Meeting,
Maui, U.S.A.，1985, 12．
5. Masayuki Hiramatsu, Toshitaka Nabeshima, Kiyoshi Matsuno, Hiroshi Furukawa,
Tsutomu Kameyama，Modulation of opioid receptor function by acute and
chronic phencyclidine administration，IUPHAR 9th International
Congress of Pharmacology, London，1984, 7．
4. Kazumasa Yamaguchi, Toshitaka Nabeshima, Masayuki Hiramatsu, Kiyofumi
Yamada, Hiroshi Furukawa and Tsutomu Kameyama，Serotonergic and
dopaminergic involvement in phencyclidine-induced stereotyped
behavior，9th Meeting of International Society for Neurochemistry,
Vancouver, Canada，1983, 7．
3. Toshitaka Nabeshima, Masayuki
Hiramatsu, Manabu Amano, Hiroshi Furukawa,
Tsutomu Kameyama，Interaction between phencyclidine and morphine in
relation to methionine-enkephalin contents in discrete brain areas of
mice，9th Meeting of International Society for Neurochemistry,
Vancouver, Canada，1983, 7．
2. Toshitaka Nabeshima, Kazumasa Yamaguchi, Kiyofumi Yamada,
Masayuki Hiramatsu, Hiroshi Furukawa, Tsutomu Kameyama，Sex differences in
pharmacological actions of phencyclicine in rats，Joint France-U.S.A.
Seminar: Chemistry, Pharmacology, Present and Future of the
Therapeutic Applications and Drug Abuse Aspects of
Arylcyclohexylamines, La Grande Motte, France，1982, 9．
1. Toshitaka Nabeshima, Masayuki
Hiramatsu, Manabu Amano, Hiroshi Furukawa,
Ing K. Ho, Tsutomu Kameyama，Effect of acute and chronic
administrations phencyclidine on methionine-enkephalin contents in
mouse brain，Joint France-U.S.A. Seminar: Chemistry, Pharmacology,
Present and Future of the Therapeutic Applications and Drug Abuse
Aspects of Arylcyclohexylamines, La Grande Motte, France，1982,
9．